Our Partners
GNS has partnered with several organizations and companies, including:
Biogen Idec
Area: Clinical biomarkers and targets for inflammation
CombinatoRx
Area: Discovery of mechanisms of synergy for combination therapies
The Jackson Laboratory
Area: Metabolic disease
Johannes Kepler University, Linz
Area: Academic collaborator in data processing algorithms
Johnson & Johnson
Area: Receptor Tyrosine Kinase inhibitor drug candidates for cancer
H. Lee Moffitt Cancer Center & Research Institute
Area: Cancer disease mechanisms
The M.D. Anderson Cancer Center at The University of Texas
Area: Glioblastoma (Brain Cancer)
Novartis
Area: Drug toxicity
"An integrated approach for inference and mechanistic modeling for advancing drug development"
Sergej V. Aksenov, Bruce Church, Anjali Dhiman, Anna Georgieva, Ramesh Sarangapani, Gabriel Helmlinger, Iya G. Khalil, FEBS Letters (2005).
Pfizer
Areas: Multiple
University of Budapest
Area: Oncology drug resistance mechanisms
University of California, San Francisco
Area: Cancer signaling pathways
University of California, San Diego
Area: Cancer & metabolic pathways
Weill Cornell Medical School
Area: Discovery of mechanisms of synergy for combination therapies FTIs and taxanes